Obalon_Logo_Teal_2c.jpg
Obalon Announces Fourth Quarter and Full Year 2020 Financial Results
12 mars 2021 19h12 HE | Obalon Therapeutics, Inc.
SAN DIEGO, March 12, 2021 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon_Logo_Teal_2c.jpg
Obalon Announces Third Quarter 2020 Financial Results
06 nov. 2020 16h45 HE | Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon_Logo_Teal_2c.jpg
Obalon Announces Consulting Agreement As Part of Strategy To Seek Coverage and Reimbursement for The Obalon Balloon System
13 août 2020 07h00 HE | Obalon Therapeutics, Inc.
SAN DIEGO, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
Obalon_Logo_Teal_2c.jpg
Obalon Announces Second Quarter 2020 Financial Results
30 juil. 2020 06h38 HE | Obalon Therapeutics, Inc.
SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon_Logo_Teal_2c.jpg
Obalon Announces First Quarter 2020 Financial Results and Business Update
19 juin 2020 06h15 HE | Obalon Therapeutics, Inc.
SAN DIEGO, June 19, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
Obalon_Logo_Teal_2c.jpg
Obalon Announces Further Impacts Related To Covid-19 Crisis and Current Business Environment
11 mai 2020 08h30 HE | Obalon Therapeutics, Inc.
SAN DIEGO, May 11, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and...
Obalon_Logo_Teal_2c.jpg
William Plovanic Resigns as President and Chief Executive Officer and Will Continue to Serve Solely as Director
08 mai 2020 08h00 HE | Obalon Therapeutics, Inc.
SAN DIEGO, May 08, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...
Obalon_Logo_Teal_2c.jpg
Obalon Gas-Filled Balloon Not Subject of Fourth FDA Letter to Health Care Providers Related To Serious Risks, Including Death, With Liquid-Filled Intragastric Balloons
28 avr. 2020 09h00 HE | Obalon Therapeutics, Inc.
SAN DIEGO, April 28, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon_Logo_Teal_2c.jpg
Obalon Engages Canaccord Genuity to Explore Financial and Strategic Alternatives
25 mars 2020 08h30 HE | Obalon Therapeutics, Inc.
SAN DIEGO, March 25, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...
Obalon_Logo_Teal_2c.jpg
Obalon Temporarily Suspends New Patient Sales at Its Retail Treatment Centers Due to Coronavirus Pandemic
17 mars 2020 17h21 HE | Obalon Therapeutics, Inc.
SAN DIEGO, Calif., March 17, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...